
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ULTRACET | Johnson & Johnson | N-021123 DISCN | 2001-08-15 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CONZIP | Cipher Pharmaceuticals | N-022370 RX | 2010-05-07 | 3 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| banana boat kids ultramist tear free spf 30 | OTC monograph final | 2010-03-25 |
| banana boat ultramist baby tear free continuous spf 50 | OTC monograph final | 2010-03-18 |
| banana boat ultramist kids spf 50 factor de proteccion solar 50 | OTC monograph final | 2010-03-21 |
| banana boat ultramist kids tear free lotion spf 50 | OTC monograph final | 2010-03-21 |
| banana boat ultramist sport performance spf 50 | OTC monograph final | 2010-03-20 |
| conzip | New Drug Application | 2023-12-22 |
| direct rx | ANDA | 2015-09-09 |
| durela | Export only | 2024-12-06 |
| fulvicin p/g 165 | ANDA | 2025-02-10 |
| griseofulvin | ANDA | 2021-07-21 |
Expiration | Code | ||
|---|---|---|---|
CELECOXIB / TRAMADOL HYDROCHLORIDE, SEGLENTIS, KOWA PHARMS | |||
| 2024-10-15 | NP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Tramadol Hydrochloride, Qdolo, Athena | |||
| 11103452 | 2040-09-01 | DP | U-3197 |
| 11752103 | 2040-09-01 | DP | U-3197 |
| Celecoxib / Tramadol Hydrochloride, Seglentis, Kowa Pharms | |||
| 8846744 | 2031-06-03 | DP | |
| 8598152 | 2030-04-19 | DS, DP | |
| 9012440 | 2030-04-19 | DS, DP | |
| 10238668 | 2030-04-19 | DS, DP | U-3244 |
| 10245276 | 2030-04-19 | DS, DP | |
| 10548909 | 2030-04-19 | U-3244 | |
| 11478488 | 2030-04-19 | U-3244 | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | — | — | 2 | — | 1 | 3 |
| Acute pain | D059787 | — | R52 | — | — | 2 | — | — | 2 |
| Postoperative pain | D010149 | — | G89.18 | — | — | 2 | — | — | 2 |
| Low back pain | D017116 | — | M54.5 | — | — | 1 | — | — | 1 |
| Drug common name | Tramadol |
| INN | tramadol |
| Description | (R,R)-tramadol is a 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol in which both stereocentres have R-configuration; the (R,R)-enantiomer of the racemic opioid analgesic tramadol, it exhibits ten-fold higher analgesic potency than the (S,S)-enantiomer. It has a role as a delta-opioid receptor agonist, a kappa-opioid receptor agonist, a mu-opioid receptor agonist, an adrenergic uptake inhibitor, an antitussive, a capsaicin receptor antagonist, a muscarinic antagonist, a nicotinic antagonist, a NMDA receptor antagonist, an opioid analgesic, a serotonergic antagonist, a serotonin uptake inhibitor and a metabolite. It is a conjugate base of a (R,R)-tramadol(1+). It is an enantiomer of a (S,S)-tramadol. |
| Classification | Small molecule |
| Drug class | analgesics (mixed opiate receptor agonists/antagonists) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1cccc(C2(O)CCCCC2CN(C)C)c1 |
| PDB | — |
| CAS-ID | 2914-77-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1237044 |
| ChEBI ID | 75722 |
| PubChem CID | 33741 |
| DrugBank | DB00193 |
| UNII ID | 39J1LGJ30J (ChemIDplus, GSRS) |











